News article
Launch of Innovative Medicines Initiative 2 (IMI 2) Call 20
21/01/2020
Funding opportunities in cancer, tuberculosis, vaccines, psoriatic arthritis and drugs based on proteins.
The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry, represented by the European Federation of Pharmaceutical Industries and Associations (EFPIA).